- Trials with a EudraCT protocol (194)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (33)
194 result(s) found for: Partial Seizure.
Displaying page 1 of 10.
EudraCT Number: 2009-016996-31 | Sponsor Protocol Number: P09-004 | Start Date*: 2010-06-28 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Randomized, Multicenter, Double-Blind, Placebo–Controlled, Parallel-Group, Phase 3 Study to Evaluate the Efficacy and Safety of USL255 as Adjunctive Therapy in Patients with Refractory Partial-O... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Refractory partial-onset seizures with or without secondary generalization | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001982-33 | Sponsor Protocol Number: E2090-E044-401 | Start Date*: 2005-09-05 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: An open label study of Zonegran (zonisamide) in patients with partial onset seizures. | |||||||||||||
Medical condition: Indicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) AT (Completed) SE (Completed) DK (Completed) FI (Completed) DE (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005440-25 | Sponsor Protocol Number: SP904 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with and without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005439-27 | Sponsor Protocol Number: SP902 | Start Date*: 2009-02-16 | ||||||||||||||||
Sponsor Name:UCB BIOSCIENCES, Inc. | ||||||||||||||||||
Full Title: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400mg/day Monotherapy in Subjects with Partial-onset Seizures | ||||||||||||||||||
Medical condition: Partial-onset seizures (with or without secondary generalization) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) AT (Completed) DK (Completed) PT (Not Authorised) IT (Completed) FR (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000152-16 | Sponsor Protocol Number: SP774 | Start Date*: 2004-10-13 | |||||||||||
Sponsor Name:SCHWARZ BIOSCIENCES GmbH; A member of the UCB group | |||||||||||||
Full Title: An international open-label extension trial to determine safety and efficacy of long-term oral SPM 927 in patients with partial seizures | |||||||||||||
Medical condition: Partial seizures | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) HU (Completed) CZ (Completed) FI (Completed) SE (Completed) ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004586-84 | Sponsor Protocol Number: N01364 | Start Date*: 2015-11-12 | ||||||||||||||||
Sponsor Name:UCB Pharma SA | ||||||||||||||||||
Full Title: A multicenter, open-label, randomized, parallel-group, active-controlled study comparing the efficacy and safety of Levetiracetam to Carbamazepine used as monotherapy in subjects (≥16 years) newly ... | ||||||||||||||||||
Medical condition: Epilepsy Partial Seizures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-004465-87 | Sponsor Protocol Number: CTRI476BRU02 | Start Date*: 2016-05-04 | ||||||||||||||||
Sponsor Name:Novartis Pharmaceuticals | ||||||||||||||||||
Full Title: A 24-week Prospective Open-label Multicenter Study to Evaluate the Effect on Seizure Frequency, Safety and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures | ||||||||||||||||||
Medical condition: Epilepsy, Partial Seizures | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-001433-39 | Sponsor Protocol Number: NBI-921352-FOS2021 | Start Date*: 2021-09-08 | |||||||||||
Sponsor Name:Neurocrine Biosciences, Inc. | |||||||||||||
Full Title: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of NBI-921352 as Adjunctive Therapy in Adult Subjects ... | |||||||||||||
Medical condition: Focal Onset Seizures (FOS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) IT (Ongoing) BE (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017904-95 | Sponsor Protocol Number: P09-005 | Start Date*: 2010-06-28 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: Open-Label Extension Study to Evaluate the Safety of USL255 as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures who had Participated in P09-004, a Randomized, Multicenter, Doub... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Refractory partial-onset seizures with or without secondary generalization | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) DE (Completed) ES (Completed) GR (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004333-57 | Sponsor Protocol Number: N01221 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:UCB Japan Co., Ltd. | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled 5 Parallel Groups, Confirmatory Trial on the Efficacy and Safety of Levetiracetam used as add-on Therapy at doses of 0.5 to 3 g/day in Patients From 1... | |||||||||||||
Medical condition: Epilepsies Partial | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002322-22 | Sponsor Protocol Number: SP757 | Start Date*: 2005-01-12 | |||||||||||
Sponsor Name:SCHWARZ BIOSCIENCES Inc. | |||||||||||||
Full Title: A multi-center, open-label trial to investigate the safety and tolerability of intravenous SPM 927 as replacement for oral SPM 927 in subjects with partial seizures with or without secondary genera... | |||||||||||||
Medical condition: partial seizures with or without secondary generalization | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) SE (Completed) DE (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001515-36 | Sponsor Protocol Number: 200776 | Start Date*: 2017-08-11 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline K.K. | ||||||||||||||||||
Full Title: Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study | ||||||||||||||||||
Medical condition: Partial seizures (including secondary generalized seizures) or tonic-clonic seizures with or without myoclonus but without other generalized seizure type(s) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002167-16 | Sponsor Protocol Number: E2007-G000-311 | Start Date*: 2017-01-30 | ||||||||||||||||
Sponsor Name:Eisai Limited | ||||||||||||||||||
Full Title: An Open-Label, Multicenter Study with an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension when Administered as an Adjunctive Th... | ||||||||||||||||||
Medical condition: Epilepsy : 1) Partial-Onset Seizures (POS) 2) Primary Generalized Tonic-Clonic Seizures (PGTC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) LV (Completed) ES (Completed) PL (Completed) BE (Completed) IT (Completed) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003420-37 | Sponsor Protocol Number: A0081042 | Start Date*: 2014-05-16 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF PREGABALIN AS ADJUNCTIVE THERAPY IN CHILDREN 1 MONTH THROUGH <4 YEARS OF AGE WITH PARTIAL ONSET S... | |||||||||||||
Medical condition: Partial onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) NL (Prematurely Ended) ES (Completed) DE (Completed) PL (Completed) SK (Completed) GR (Completed) PT (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002713-32 | Sponsor Protocol Number: N01367 | Start Date*: 2015-03-11 | |||||||||||
Sponsor Name:Korea UCB Co. Ltd. | |||||||||||||
Full Title: A Multi-Center, Open-label, Randomized Study to Evaluate the Long Term Effectiveness of Levetiracetam as Monotherapy in Comparison With Oxcarbazepine in Subjects With Newly or Recently Diagnosed Pa... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017961-52 | Sponsor Protocol Number: CBGG492A2207 | Start Date*: 2010-05-06 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 12-week, multi-center,randomized, double-blind, placebo-controlled efficacy and safety study examining seizure frequency of BGG492 capsules administration orally three times daily (TID) as adjunc... | |||||||||||||
Medical condition: refractory partial-onset seizures | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) IT (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001318-32 | Sponsor Protocol Number: P261-401 | Start Date*: 2011-11-17 | |||||||||||
Sponsor Name:Upsher-Smith Laboratories, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects with Seizure Clusters ARTEMIS-1: Acute Rescu... | |||||||||||||
Medical condition: epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001887-55 | Sponsor Protocol Number: SCO/BIA-2093-305 | Start Date*: 2007-10-12 | |||||||||||
Sponsor Name:BIAL - Portela & Ca, S.A. | |||||||||||||
Full Title: Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as adjunctive therapy for refractory partial seizures in children: a double-blind, randomised, placebo-controlled, parallel-group, multice... | |||||||||||||
Medical condition: children and adolescents with refractory partial epileptic seizures | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) HU (Completed) CZ (Completed) AT (Completed) FR (Completed) SK (Completed) IT (Completed) ES (Completed) GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005065-64 | Sponsor Protocol Number: CBGG492A2202 | Start Date*: 2009-03-12 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multicenter, double-blind, randomized, placebo-controlled, two-arm parallel-group study of BGG492 as monotherapy in individuals with refractory partial seizures undergoing inpatient evaluation fo... | |||||||||||||
Medical condition: Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016849-25 | Sponsor Protocol Number: A0081047 | Start Date*: 2010-03-15 | |||||||||||
Sponsor Name:Pfizer Inc | |||||||||||||
Full Title: A DOUBLE-BLIND, RANDOMIZED, MULTICENTER EFFICACY AND SAFETY STUDY OF PREGABALIN (LYRICA) AS MONOTHERAPY IN PATIENTS WITH PARTIAL SEIZURES | |||||||||||||
Medical condition: Partial Seizures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.